Related Experiment Video
Updated: Jun 27, 2026

Spatiotemporal Control of Protein Activity through Optogenetic Allosteric Regulation
Published on: October 4, 2024
Role of Src signal transduction pathways in scatter factor-mediated cellular protection
Saijun Fan1, Qinghui Meng, John J Laterra
1Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA.
Abstract:
Scatter factor (SF) (hepatocyte growth factor) is a pleiotrophic cytokine that accumulates in tumors, where it may induce invasion, angiogenesis, and chemoresistance. We have studied the mechanisms by which SF and its receptor (c-Met) protect cells against the DNA-damaging agent adriamycin (ADR) as a model for chemoresistance of SF/c-Met-overexpressing tumors. Previous studies identified a phosphatidylinositol 3-kinase/c-Akt/Pak1/NF-kappaB cell survival pathway in DU-145 prostate cancer and Madin-Darby canine kidney epithelial cells. Here we studied Src signaling pathways involved in SF cell protection. Src enhanced basal and SF stimulated NF-kappaB activity and SF protection against ADR, in a manner dependent upon its kinase and Src homology 3 domains; and endogenous Src was required for SF stimulation of NF-kappaB activity and cell protection. The ability of Src to enhance SF stimulation of NF-kappaB activity was due, in part, to its ability to stimulate Akt and IkappaB kinase activity; and Src-mediated stimulation of NF-kappaB was due, in part, to a Rac1/MKK3/6/p38 pathway and was Akt-dependent. SF caused the activation of Src and the Rac1 effector Pak1. Furthermore, SF induced activating phosphorylations of MKK3, MKK6, and p38 within the c-Met signalsome in an Src-dependent manner. The NF-kappaB-inducing kinase was found to act downstream of TAK1 (transforming growth factor-beta-activated kinase 1) as a mediator of SF- and Src-stimulated NF-kappaB activity. Finally, the Src/Rac1/MKK3/6/p38 and Src/TAK1/NF-kappaB-inducing kinase pathways exhibited cross-talk at the level of MKK3. These findings delineate some novel signaling pathways for SF-mediated resistance to ADR.
Insights
Scatter factor (SF) and its receptor c-Met activate Src signaling pathways, enhancing NF-kappaB activity and promoting chemoresistance against adriamycin (ADR). These novel pathways involve Src, Rac1, MKK3/6, p38, TAK1, and NF-kappaB-inducing kinase.
Area of Science:
- Cell Biology
- Molecular Oncology
- Signal Transduction
Background:
- Scatter factor (SF), also known as hepatocyte growth factor, is implicated in tumor invasion, angiogenesis, and chemoresistance.
- SF/c-Met signaling pathways are crucial for cellular survival and resistance to DNA-damaging agents like adriamycin (ADR).
- Previous research identified a phosphatidylinositol 3-kinase/c-Akt/Pak1/NF-kappaB survival pathway in SF-mediated chemoresistance.
Purpose of the Study:
- To elucidate the mechanisms by which SF and its receptor c-Met confer chemoresistance against adriamycin (ADR).
- To investigate the role of Src signaling pathways in SF-mediated cell protection and NF-kappaB activation.
- To delineate novel signaling cascades involved in SF/c-Met-driven resistance to DNA-damaging chemotherapy.
Main Methods:
- Investigated the involvement of Src signaling in SF-mediated protection against adriamycin (ADR) using cancer cell models.
- Assessed the impact of Src kinase and Src homology 3 domains on NF-kappaB activity and ADR resistance.
- Utilized Western blotting and kinase assays to analyze the activation of key signaling molecules including Akt, IkappaB kinase, Rac1, MKK3/6, p38, TAK1, and NF-kappaB-inducing kinase.
Main Results:
- Endogenous Src is essential for SF-stimulated NF-kappaB activity and cell protection against ADR.
- Src enhances SF-induced NF-kappaB activation by stimulating Akt and IkappaB kinase activity.
- SF activates Src and downstream pathways including Rac1/MKK3/6/p38 and Src/TAK1/NF-kappaB-inducing kinase, contributing to ADR resistance.
Conclusions:
- Src signaling pathways play a critical role in SF/c-Met-mediated chemoresistance.
- Novel cross-talk between Src/Rac1/MKK3/6/p38 and Src/TAK1/NF-kappaB-inducing kinase pathways contributes to SF-driven NF-kappaB activation.
- These findings provide new insights into the molecular mechanisms underlying chemoresistance in SF/c-Met-overexpressing tumors.
Related Concept Videos
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Intracellular Signaling Affects Focal Adhesions
Some...
Regulation of Hematopoietic Stem Cells
Amplifying Signals via Enzymatic Cascade
The JAK-STAT Signaling Pathway
